Financial statements Elfa Pharm Polska
Balance sheet data of ELFA PHARM POLSKA
|
Year
|
2018
|
2019
|
2020
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 72 270,82 | 71 428,00 | 67 730,82 | 67 241,82 | 66 997,32 |
| A. Fixed assets | 30 000,00 | 30 000,00 | 30 000,00 | 30 000,00 | 0,00 |
| B. Current assets | 39 770,82 | 38 928,00 | 35 230,82 | 34 741,82 | 64 497,32 |
| C. Share capital contributions (basic funds) | 2 500,00 | 2 500,00 | 2 500,00 | 2 500,00 | 2 500,00 |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 72 270,82 | 71 428,00 | 67 730,82 | 67 241,82 | 66 997,32 |
| A. Equity | 56 772,42 | 67 306,32 | 63 011,82 | 64 872,82 | 64 751,32 |
| B. Liabilities and provisions for liabilities | 15 498,40 | 4 121,68 | 4 719,00 | 2 369,00 | 2 246,00 |
| I. Long-term liabilities | - | - | 0,00 | - | - |
| II. Short-term liabilities | 15 498,40 | 4 121,68 | 4 719,00 | 2 369,00 | 2 246,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.